Find Enclomiphene manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Trans-clomiphene, Enclomifene, 15690-57-0, Trans-clomifene, Enclomifeno, Enclomifenum
Molecular Formula
C26H28ClNO
Molecular Weight
406.0  g/mol
InChI Key
GKIRPKYJQBWNGO-OCEACIFDSA-N
FDA UNII
R6D2UI4FLS

Enclomiphene
The trans or (E)-isomer of clomiphene.
1 2D Structure

Enclomiphene

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine
2.1.2 InChI
InChI=1S/C26H28ClNO/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23/h5-18H,3-4,19-20H2,1-2H3/b26-25+
2.1.3 InChI Key
GKIRPKYJQBWNGO-OCEACIFDSA-N
2.2 Other Identifiers
2.2.1 UNII
R6D2UI4FLS
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Enclomifene

2. En-clomiphene

3. Enclomiphen

4. (e)-2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)triethylamine

5. Trans-clomiphene

2.3.2 Depositor-Supplied Synonyms

1. Trans-clomiphene

2. Enclomifene

3. 15690-57-0

4. Trans-clomifene

5. Enclomifeno

6. Enclomifenum

7. Isomer B

8. Rmi 16,289

9. Isomer-b

10. R6d2ui4fls

11. Ici 46476

12. Rmi-16,289

13. (e)-2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)triethylamine

14. Ici-46476

15. Rmi-16289

16. Dtxsid201318048

17. Trans-2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-n,n-diethylethanamine

18. Ethanamine, 2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-n,n-diethyl-, (e)-

19. Enclomiphen

20. En-clomiphene

21. Trans Clomiphene

22. 2-(4-((e)-2-chloro-1,2-di(phenyl)ethenyl)phenoxy)-n,n-diethylethanamine

23. 2-[4-[(e)-2-chloro-1,2-di(phenyl)ethenyl]phenoxy]-n,n-diethylethanamine

24. Clomiphene Trans-

25. Refchem:136761

26. Dtxcid50196644

27. (2-(4-((e)-2-chloro-1,2-diphenylethenyl)phenoxy)ethyl)diethylamine

28. Clomifene

29. Enclomiphene [usan]

30. Cisclomiphene

31. Enclomifene [inn]

32. Clomiphene Trans-form

33. Ethanamine, 2-[4-[(1e)-2-chloro-1,2-diphenylethenyl]phenoxy]-n,n-diethyl-

34. 2-[4-[(e)-2-chloro-1,2-diphenylethenyl]phenoxy]-n,n-diethylethanamine

35. Clomifeno

36. Enclomiphene (usan)

37. Transclomifenum

38. Clomifenum

39. 2-[4-[(e)-2-chloro-1,2-diphenyl-vinyl]phenoxy]-n,n-diethyl-ethanamine

40. Enclomifenum [inn-latin]

41. Enclomifeno [inn-spanish]

42. Clomiphene Citrate (z,e)

43. Unii-r6d2ui4fls

44. 2-{4-[(e)-2-chloro-1,2-diphenylethenyl]phenoxy}-n,n-diethylethanamine

45. Trans-enclomiphene

46. Clomifene (tn)

47. Clomifene (inn)

48. Ncgc00179503-02

49. 53q

50. Trans-2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)triethylamine

51. Prestwick2_000397

52. Prestwick3_000397

53. Chembl954

54. Schembl34893

55. Bspbio_000613

56. Mls001304092

57. Mls006011852

58. Bidd:er0223

59. Bidd:gt0216

60. Enclomiphene [who-dd]

61. {2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]ethyl}diethylamine

62. 2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-n,n-diethylethanamine

63. 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-n,n-diethylethanamine

64. Bpbio1_000675

65. Gtpl7619

66. Bdbm55354

67. Cid_1548953

68. Cid_6420009

69. Hms2090o17

70. Hms2232e06

71. Clomiphene Trans-form [mi]

72. Mfcd00867469

73. Stk525981

74. Triethylamine, 2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)-, (e)-

75. Akos005459442

76. Db06735

77. Ncgc00179503-01

78. Ncgc00179503-12

79. Da-63191

80. Smr000718756

81. Smr004703502

82. Hy-118861

83. Cs-0069846

84. Ns00121637

85. C06917

86. D07726

87. D08910

88. H20724

89. 911c455

90. Brd-k04218075-048-03-4

91. 1-(p-.beta.-diethylaminoethoxyphenyl)-1,2-diphenyl-2-chloroethylene

92. 1-[(e)-2-chloro-1,2-diphenylethenyl]-4-methoxybenzene; Clomiphene

93. 2-{4-[(e)-2-chloro-1,2-diphenylethenyl]phenoxy}-n,n-diethylethan-1-amine

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 406.0 g/mol
Molecular Formula C26H28ClNO
XLogP37.2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count9
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area12.5
Heavy Atom Count29
Formal Charge0
Complexity481
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Used mainly in female infertility due to anovulation (e.g. due to polycystic ovary syndrome) to induce ovulation.



5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Estrogen Antagonists

Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.


Fertility Agents, Female

Compounds which increase the capacity to conceive in females.


Selective Estrogen Receptor Modulators

A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63)


5.2 ATC Code

G - Genito urinary system and sex hormones

G03 - Sex hormones and modulators of the genital system

G03G - Gonadotropins and other ovulation stimulants

G03GB - Ovulation stimulants, synthetic

G03GB02 - Clomifene


ATCvet Code

QG - Genito urinary system and sex hormones

QG03 - Sex hormones and modulators of the genital system

QG03G - Gonadotropins and other ovulation stimulants

QG03GB - Ovulation stimulants, synthetic

QG03GB02 - Clomifene


G03GB02


5.3 Absorption, Distribution and Excretion

Absorption

Based on early studies with 14 C-labeled clomifene, the drug was shown to be readily absorbed orally in humans.


Route of Elimination

Based on early studies with 14C-labeled clomiphene citrate, the drug was shown to be readily absorbed orally in humans and excreted principally in the feces. Mean urinary excretion was approximately 8% with fecal excretion of about 42%.


5.4 Metabolism/Metabolites

Hepatic


5.5 Biological Half-Life

5-7 days


5.6 Mechanism of Action

Clomifene has both estrogenic and anti-estrogenic properties, but its precise mechanism of action has not been determined. Clomifene appears to stumulate the release of gonadotropins, follicle-stimulating hormone (FSH), and leuteinizing hormone (LH), which leads to the development and maturation of ovarian follicle, ovulation, and subsequent development and function of the coprus luteum, thus resulting in pregnancy. Gonadotropin release may result from direct stimulation of the hypothalamic-pituitary axis or from a decreased inhibitory influence of estrogens on the hypothalamic-pituitary axis by competing with the endogenous estrogens of the uterus, pituitary, or hypothalamus. Clomifene has no apparent progestational, androgenic, or antrandrogenic effects and does not appear to interfere with pituitary-adrenal or pituitary-thyroid function.


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty